News
AAPG
17.56
-0.79%
-0.14
Ascentage Pharma grants 3,223,685 RSUs under 2022 employee share scheme
PUBT · 8h ago
Ascentage Pharma Group International files Form 3 for Chief Business Officer Faical Miyara
PUBT · 1d ago
Weekly Report: what happened at AAPG last week (0622-0626)?
Weekly Report · 1d ago
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga · 4d ago
Weekly Report: what happened at AAPG last week (0615-0619)?
Weekly Report · 06/22 09:14
Ascentage Pharma assumed with an Outperform at Oppenheimer
TipRanks · 06/15 11:24
Weekly Report: what happened at AAPG last week (0608-0612)?
Weekly Report · 06/15 09:14
Reported Sunday, Ascentage Pharma's Olverembatinib And Lisaftoclax Demonstrate Strong Clinical Data Across Chronic Myeloid Leukemia, Ph+ ALL And CLL/SLL In Seventeen Updates At EHA2026 Congress
Benzinga · 06/15 06:46
Ascentage Pharma reports updated Phase 3 POLARIS-1 data for olverembatinib in newly diagnosed Ph+ ALL at EHA 2026
PUBT · 06/15 03:51
Ascentage Pharma announces clinical updates from EHA2026
TipRanks · 06/14 23:50
Ascentage Pharma presents updated Phase III POLARIS-1 data for olverembatinib in newly diagnosed Ph+ ALL at EHA 2026
PUBT · 06/14 23:23
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
Barchart · 06/14 18:30
B. Riley Securities Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $45
Benzinga · 06/10 18:06
Ascentage Pharma initiated with a Buy at B. Riley
TipRanks · 06/10 12:29
Weekly Report: what happened at AAPG last week (0601-0605)?
Weekly Report · 06/08 09:13
Guotai Haitong Remains a Buy on Ascentage Pharma Group International (6855)
TipRanks · 06/02 05:45
Piper Sandler Keeps Their Buy Rating on Ascentage Pharma Group International Unsponsored ADR (AAPG)
TipRanks · 06/01 13:30
Ascentage Pharma Showcases First Pediatric Alrizomadlin Data at ASCO 2026
TipRanks · 06/01 12:33
Weekly Report: what happened at AAPG last week (0525-0529)?
Weekly Report · 06/01 09:14
Ascentage Highlights Tumor Response Data in Pediatric Cancer Study
Benzinga · 06/01 07:46
More
Webull provides a variety of real-time AAPG stock news. You can receive the latest news about Ascentage Pharma Group International through multiple platforms. This information may help you make smarter investment decisions.
About AAPG
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.